Detalles de la búsqueda
1.
Pulmonary lesion after surgery for renal cancer: progression or new primary?
World J Urol
; 42(1): 361, 2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38814376
2.
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer.
Eur J Nucl Med Mol Imaging
; 50(8): 2548-2560, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36933074
3.
Boosting Interleukin-12 Antitumor Activity and Synergism with Immunotherapy by Targeted Delivery with isoDGR-Tagged Nanogold.
Small
; 15(45): e1903462, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31523920
4.
Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?
Urol Int
; 102(3): 269-276, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30695782
5.
Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer.
BJU Int
; 121(3): 421-427, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29063734
6.
Case of the Month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses.
BJU Int
; 131(4): 434-436, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36468262
7.
Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection.
Eur Radiol
; 28(5): 1969-1976, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29270644
8.
Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer.
Urol Int
; 98(3): 290-297, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28142141
9.
Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades.
BJU Int
; 117(5): 740-7, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25787671
10.
Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion.
World J Urol
; 34(8): 1139-45, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26670425
11.
Oncological predictive value of the 2004 World Health Organisation grading classification in primary T1 non-muscle-invasive bladder cancer. A step forward or back?
BJU Int
; 115(2): 267-73, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25756136
12.
Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study.
BJU Int
; 115(4): 537-45, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25130593
13.
Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score.
BJU Int
; 113(3): 399-407, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24053339
14.
The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer.
J Urol
; 189(3): 854-9, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23022004
15.
In reply to: Lawless et al. Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.
Histopathology
; 72(2): 361-362, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28851130
16.
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration.
Bioengineering (Basel)
; 10(8)2023 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37627838
17.
Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool.
Prostate
; 72(5): 499-506, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22468270
18.
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum.
Prostate
; 72(2): 186-92, 2012 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21538428
19.
There is no way to identify patients who will harbor small volume, unilateral prostate cancer at final pathology. implications for focal therapies.
Prostate
; 72(8): 925-30, 2012 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21965006
20.
Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients.
Cancer
; 118(4): 973-80, 2012 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21751185